Biotech Merger Creates OSPRI to Revolutionize Infectious Disease Testing with $30M Backing
The merger of Community Direct DX, Scienetix, and Advanta Genetics R&D into OSPRI creates a vertically-integrated molecular testing platform that reduces PCR testing costs by 20-50% and time by 50-70%, addressing critical accessibility barriers in healthcare diagnostics.
